162 related articles for article (PubMed ID: 1658919)
21. Comparison of neurone-specific enolase and pro-gastrin releasing peptide in the prognostic evaluation of small cell lung cancer patients.
Satoh H; Kagohashi K; Kurishima K; Ishikawa H; Ohtsuka M
Clin Oncol (R Coll Radiol); 2006 Nov; 18(9):720. PubMed ID: 17100161
[No Abstract] [Full Text] [Related]
22. Values and limits of combined use of 4 tumor markers (CEA, TPA, NSE and SCC) in un-treated patients with lung cancer.
Cuomo A; Capra R; Greco S; Cacciani GC; Greco F; Franchini D; Bonelli P; Gavaruzzi G; Ugolotti G
Acta Biomed Ateneo Parmense; 1993; 64(5-6):171-84. PubMed ID: 7992555
[No Abstract] [Full Text] [Related]
23. Discriminant analysis on small cell lung cancer and non-small cell lung cancer by means of NSE and CYFRA-21.1.
Paone G; De Angelis G; Munno R; Pallotta G; Bigioni D; Saltini C; Bisetti A; Ameglio F
Eur Respir J; 1995 Jul; 8(7):1136-40. PubMed ID: 7589398
[TBL] [Abstract][Full Text] [Related]
24. [Usefulness of carcinoembryonic antigen (CEA), tissue polypeptide antigen (TPA), enolase (NSE) and thymidine-kinase (TK) in the monitoring and prognosis of primary carcinoma of the lung].
De Angelis G; De Marinis F; Bigioni D; Migliorino MR; Alma MG; Pigorini F
J Nucl Med Allied Sci; 1990; 34(4 Suppl):135-40. PubMed ID: 1965445
[No Abstract] [Full Text] [Related]
25. Bronchial biopsies--in praise of an H&E section.
Pandit D; Griffiths D; Edwards J
Histopathology; 2006 Jul; 49(1):96-7. PubMed ID: 16842256
[No Abstract] [Full Text] [Related]
26. [Transbronchial biopsy of the lung in the diagnosis of peripheral cancer and diffuse-disseminated processes].
Lebedev VA; Blinchevskiĭ ID
Sov Med; 1990; (9):107-11. PubMed ID: 2176348
[No Abstract] [Full Text] [Related]
27. Tumour marker evaluation in patients with lung cancer.
Seregni E; Botti C; Bogni A; Bombardieri E
Scand J Clin Lab Invest Suppl; 1995; 221():67-71. PubMed ID: 7652492
[No Abstract] [Full Text] [Related]
28. Evaluation of Cyfra 21-1 as a marker for lung cancer.
Najemnik C; Mohn-Staudner A; Vetter H; Kokron O; Baumgartner G; Scheiner W; Zwick H; Koderhold G; Alth G; Dudczak R
Wien Klin Wochenschr; 1996; 108(15):467-72. PubMed ID: 8806188
[TBL] [Abstract][Full Text] [Related]
29. Isoenzyme pattern of enolase and creatine kinase in small cell lung cancer patients.
Batandier C; Brambilla E; Nagy H; Brambilla C
Chest; 1987 Jul; 92(1):189-90. PubMed ID: 3036426
[No Abstract] [Full Text] [Related]
30. [The diagnostic values of CA242 combining other tumor markers for lung cancer].
Zhang S; Ma Y; Yang X
Zhonghua Jie He He Hu Xi Za Zhi; 1999 May; 22(5):271-3. PubMed ID: 11775851
[TBL] [Abstract][Full Text] [Related]
31. Glycosylated Alpha-1-acid glycoprotein 1 as a potential lung cancer serum biomarker.
Ayyub A; Saleem M; Fatima I; Tariq A; Hashmi N; Musharraf SG
Int J Biochem Cell Biol; 2016 Jan; 70():68-75. PubMed ID: 26563422
[TBL] [Abstract][Full Text] [Related]
32. CYFRA 21-1 in lung cancer: comparison with CEA, CA 125, SCC and NSE serum levels.
Molina R; Agusti C; Mañe JM; Filella X; Jo J; Joseph J; Giménez N; Estapé J; Ballesta AM
Int J Biol Markers; 1994; 9(2):96-101. PubMed ID: 7523548
[TBL] [Abstract][Full Text] [Related]
33. Role of biological markers and probes in lung carcinomas.
Dorreen MS
Bull Eur Physiopathol Respir; 1986; 22(2):137-46. PubMed ID: 2871878
[TBL] [Abstract][Full Text] [Related]
34. [Serum neuron-specific enolase (NSE) in patients with primary lung cancer].
Oribe H; Kato R; Noguchi S; Kai T
Rinsho Byori; 1988 Apr; 36(4):464-8. PubMed ID: 2841516
[No Abstract] [Full Text] [Related]
35. Pro-gastrin-releasing peptide (ProGRP), neuron specific enolase (NSE), carcinoembryonic antigen (CEA) and cytokeratin 19-fragments (CYFRA 21-1) in patients with lung cancer in comparison to other lung diseases.
Schneider J; Philipp M; Velcovsky HG; Morr H; Katz N
Anticancer Res; 2003; 23(2A):885-93. PubMed ID: 12820318
[TBL] [Abstract][Full Text] [Related]
36. [The dynamics of the hormonal and tumor marker levels in response to adrenaline administration in lung cancer patients].
Khudoleĭ VN; Velichko SA
Vopr Onkol; 1992; 38(10):1209-17. PubMed ID: 1343147
[TBL] [Abstract][Full Text] [Related]
37. [Creatine kinase BB and neuron specific r-enolase as biomarkers for lung cancer].
Usui A; Fujita K; Imaizumi M; Abe T; Inoue K; Matsumoto S; Kato K
Gan No Rinsho; 1987 Nov; 33(14):1763-70. PubMed ID: 2826840
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of CYFRA 21-1 in malignant and benign pleural effusions.
Toumbis M; Rasidakis A; Passalidou E; Kalomenidis J; Alchanatis M; Orphanidou D; Jordanoglou J
Anticancer Res; 1996; 16(4A):2101-4. PubMed ID: 8712750
[TBL] [Abstract][Full Text] [Related]
39. [Neuron-specific enolase as a tumor marker in small cell bronchial carcinoma].
Gasser RW; Herold M; Müller-Holzner E; Müller LC; Salzer GM; Huber H
Dtsch Med Wochenschr; 1988 Nov; 113(44):1708-13. PubMed ID: 2846253
[TBL] [Abstract][Full Text] [Related]
40. Enzyme-linked immunosorbent assay of pro-gastrin-releasing peptide for small cell lung cancer patients in comparison with neuron-specific enolase measurement.
Yamaguchi K; Aoyagi K; Urakami K; Fukutani T; Maki N; Yamamoto S; Otsubo K; Miyake Y; Kodama T
Jpn J Cancer Res; 1995 Jul; 86(7):698-705. PubMed ID: 7559089
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
